Skip to main content

sitagliptin

Generic: SITAGLIPTIN HYDROCHLORIDE·Brand: BRYNOVIN, JANUVIA, Janumet, Januvia, SITAGLIPTIN PHOSPHATE, ZITUVIO

sitagliptin: 3 clinical trials tracked.

sitagliptin evidence translation

What we can confirm

3 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about sitagliptin, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence5 indications · 2 study sponsors
Clinical Trials (3)

A Phase 1 Study to Evaluate the Effect of Multiple Doses of ABBV-722 on the Pharmacokinetics of Cocktail Probe Substrates of CYP3A and Select Transporters in Healthy Adult Subjects

NCT07567781·Phase 1·ABBV
Completed

Primary endpoint: Number of Participants with Adverse Events (AEs)

Interventionalopen12 enrolledStarted 2026-04Completion 2026-071 site · United StatesAbbVie

Comparative Effectiveness of Dulaglutide, Semaglutide, and Tirzepatide in Preventing Cardiovascular Events in Patients With Type 2 Diabetes and Obesity With or Without Atherosclerotic Cardiovascular Disease.

Active, not recruiting

Primary endpoint: Composite of myocardial infarction, stroke, or all-cause mortality.

Observational60,000 targetStarted 2026-01Completion 2026-031 site · United StatesBrigham and Women's Hospital

The GLP-1 Agonist Semaglutide for the Treatment of Metabolic Disease in Liver Transplant Recipients: A Phase IV, Randomized Trial

NCT05195944·Phase 4
Enrolling by invitation

Primary endpoint: Change in HbA1c level

InterventionalRandomizedquadruple58 targetStarted 2022-10Completion 2026-121 site · CanadaUniversity Health Network, Toronto